Argos Therapeutics (ARGS) Getting Somewhat Positive Media Coverage, Analysis Finds

Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 4.73, and a price to sales ratio of 2.36. This rating was issued on 2/23/17. State Street Corp now owns 177,494 shares of the biopharmaceutical company's stock worth $870,000 after buying an additional 18,625 shares in the last quarter. These analysts and investment firms use various valuation methods to decide a price target for a stock.

Argos Therapeutics, Inc (Argos) is an immuno-oncology company. Analyst's consensus target price is measured at $1.6000 for twelve month. The Return on Equity ratio of Argos Therapeutics, Inc.

Argos Therapeutics, Inc. (ARGS) has a market capitalization of 16.17 Million which suggests the company is a huge company further suggesting that the shares of Argos Therapeutics, Inc. The stock appeared $13.97 above its 52-week highs and is up 10.48% for the last five trades.

Maximum and minimum EPS estimate for the current quarter is projected at $-0.26 and $-0.39, respectively, according to 2 analysts. This scale runs from 1 to 5 where 1 represents Strong Buy and 5 represents Sell. Investors who are keeping close eye on the stock of Argos Therapeutics, Inc.

A number of analysts have commented on ARGS shares.

Argos Therapeutics Inc had its "hold" rating reiterated by analysts at Stifel Nicolaus. (NASDAQ:ARGS) highlighted upward shift of +53.3879% or +0.2088 points to $0.5999. The difference between Actual EPS and Estimated EPS was -0.01 Percent. Future earnings predictions are perhaps the most essential input when trying to value a company. Finally, Zacks Investment Research downgraded shares of Argos Therapeutics from a "buy" rating to a "hold" rating in a research report on Tuesday, February 7th. The company traded a volume of 12.56 million shares over average volume of 1.15 million shares. Over the same time span, the stock marked US$9.22 as its best level and the lowest price reached was US$0.31.

Moving average is significant analytical tool used to discover current price trends and the possibility for a change in an established trend. Company's distance from 20 day simple moving average is -21.46% and distance from 50-Day simple moving average is -78.15%. The Moving Average SMA50 is -64.99% while SMA200 is -85.54%. The return on equity ratio or ROE stands at 0 percent while most common profitability ratio return on investment (ROI) was -96.3 percent. The stock now shows its YTD (Year to Date) performance of -87.76 percent while its Weekly performance value is 75.92%. The Monthly and Yearly performances are -29.42 percent and -94.39 percent respectively.

ARGS has a 1-year high price of $ 13.46 and 1-year low price of $0.31.

The stock now has its Annual Dividend of $0 and an annual Dividend Yield of 0 Percent.

The company is expected to report earnings of $-0.33 a share for the next quarter.